期刊文献+

膀胱移行细胞癌多肿瘤抑制基因-1纯合子缺失及意义

Homozygous deletions of the multiple tumor suppressor gene-1 in the transitional cell carcinoma of the bladder
下载PDF
导出
摘要 目的 :了解多肿瘤抑制基因 - 1(MTS1 )在膀胱移行细胞癌中的纯合子缺失情况 ,探讨 MTS1 纯合子缺失在膀胱移行细胞癌发生与发展中的意义。方法 :收集温州医学院手术切除的膀胱移行细胞癌石蜡标本 35例 ,采用比较 PCR法检测其 MTS1 纯合子缺失情况。结果 :剔除 2例不可比标本 ,33例标本中 ,MTS1 纯合子缺失 6例 ,缺失率为 18.2 %。其中 级、 级、 级膀胱移行细胞癌 MTS1 纯合子缺失率分别为 18.2 % (2 / 11)、2 0 .0 % (3/ 15 )和 14.3% (1/ 7) ;Tis~ T1 期肿瘤和 T2 ~ T4期肿瘤 MTS1 纯合子缺失率分别为 2 2 .2 % (4 / 18)和 13.3% (2 / 15 ) ,各级和各期肿瘤的 MTS1 纯合子缺失率无显著性差异 (P >0 .0 5 )。结论 :MTS1 纯合子对膀胱移行细胞癌的发生起一定作用 。 Purpose:To understand the states of homozygous deletions of the multiple tumor suppressor gene 1(MTS1) in the transitional cell carcinoma of the bladder and their significance. Methods:Paraffin embebed specimens from 35 cases of patients with transitional cell carcinoma of the bladder was detected by the comparative PCR for homozygous deletions of MTS1.Results:Discarding 2 samples which was not comparable,homozygous loss of MTS1 was found in 6 of 33 samples ,loss rate was 18.3 %.The loss rate in grade Ⅰ,Ⅱ and Ⅲ tumor was 18.2 % (2/11), 20.0 % (3/15) and 14.3 %(1/7) respectively;the loss rate in the superficial tumors (Tis,T1) and the invasive tumors was 22.2 % (4/18) and 13.3 % (2/15) respectively.There wasn′t statistically significant difference between histological grades and between pathological stages( P > 0.05 ).Conclusions:The results showed that the homozygous deletions of MTS1 was correlated with the development in some transitional cell carcinoma of the bladder, but wasn′t correlated with the progression.
出处 《临床泌尿外科杂志》 2000年第6期268-270,共3页 Journal of Clinical Urology
关键词 膀胱移动细胞癌 多肿瘤抑制基因1 纯合子缺失 Bladder tumor Transitional cell carcinoma Gene,suppressor Polymeruse chain reaction
  • 相关文献

参考文献11

  • 1赫杰,张汝刚,朱丹,王秀琴,吴旻.食管癌c-myc基因扩增的临床意义[J].中华医学杂志,1995,75(2):94-96. 被引量:9
  • 2SpruckCH,Gonzalez-ZuluetaM,ShibataM,etal.P16geneinunculturedtumors.Science,1994,370:183~188
  • 3GibasZ,ProatGRJr,ConollyJG,etal.Nomrandomchromosomalchangeswithtransitionalcellcarcinomaofthebladder.CancerRes,1984,44:1257~1264
  • 4SmeetsW,PauwelsR,LaarakkersL,etal.NonrandomchromosomalanalysisofbladdercancerⅢ.CancerGenetCytogenet,1987,29:29~41
  • 5TsaiYC,NicholsPW,HitiAL,etal.Alleliclossesofchromosome9,11and17inhumanbladdercancer.CancerRes,1990,50:44~47
  • 6RubertJM,TokinoK,SidranskyD.Evidencefortwobladdercancersupressionlocionhumanchromosome9.CancerRes,1993,53:5093~2095
  • 7StadlerWM,ShermanJ,BohlanderSK,etal.Homozygousdeletionswithinchromosomalband9P21~22inbladdercancer.CancerRes,1994,54:2060~2063
  • 8KambA,GruisNA,Weaver-FeldhausJ,etal.Acellcycleregulatorpotentiallyinvolvedingenesisofmanytumortypes.Science,1994,364:436~440
  • 9NoboriT,MiurK,WuDJ,etal.Deletionsofthecyclin-dependentkinass-4inhibitorgeneinmultiplehumancancers.Nature,1994,368:753~756
  • 10WalkerDG,DuanW,PopovicEA,etal.Homozygousdeletionsofthemultipletumorsuppressorgeneintheprogressionofhumanastrocytomas.CancerRes,1995,55:20~23

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部